Study type: Therapeutical study (experimental study)

[Microwave hyperthermia in chronic prostatitis and prostatodynia--preliminary results]. med. app.

Mikrowellenhyperthermie bei chronischer Prostatitis und Prostatodynie - vorläufige Ergebnisse.

Published in: Helv Chir Acta 1988; 55 (3): 301-303
Journal partially peer-reviewed/peer-review process unclear

Aim of study (acc. to author)

To report preliminary results of a study on local hyperthermia treatment in chronic abacterial prostatitis and prostatodynia.

Endpoint

Exposure

Exposure Parameters
Exposure 1: 915 MHz
Exposure duration: first treatment: once or twice per week for 2 or 4 weeks; the same procedure was repeated after 1 week, 1, 3 and 6 months after the first treatment
-

Exposure 1

Main characteristics
Frequency 915 MHz
Exposure duration first treatment: once or twice per week for 2 or 4 weeks; the same procedure was repeated after 1 week, 1, 3 and 6 months after the first treatment
Modulation
Modulation type unspecified
Exposure setup
Exposure source
  • Prostathermer; 915 MHz source connected to a special applicator
Additional info Prostatic temperature of 39°C or 43°C was applied transrectally to the chronic prostatitis and prostatodynia patients. The treatment consisted of 16 groups which divided into according to: group treated with Doxyzyklin, group treated at 39.5°C or 43°C, group divided according to the frequency of treatement and group divided according to duration of treatment.
Parameters

No parameters are specified for this exposure.

Exposed system:

Methods Endpoint/measurement parameters/methodology

Investigated system:
Investigated organ system:
Time of investigation:
  • after exposure

Main outcome of study (acc. to author)

Objective parameters like uroflow, residual urine and urinalysis were not effected by hyperthermia. Marked subjective improvement, however, was noted in all of the patients after a follow-up of six months. Although the mechanism is still unknown, local hyperthermia seems to be a good palliative treatment in chronic abacterial prostatitis and prostatodynia.

Study character:

Study funded by